Nektar Therapeutics (NKTR) Surged To A New High On Q4 Results

Nektar Therapeutics (NKTR) reported a fourth quarter loss of $0.21 per share after the close Thursday, compared to the loss of $0.28 per share a year ago. The consensus estimate was for a loss of $0.35 per share.

from RTT - Before the Bell http://ift.tt/2oPWFpH
via IFTTT